TAS e.V. - "Transparency in Drug Studies" aims to analyze existing scientific findings and preclinical data concerning tumor therapy combined with methadone. The analysis may serve as an important prerequisite for larger clinical trials!
TAS e.V. is a courageous group of young scientists that works transparently and independently of economic interests. Pharmaceutical studies are analyzed, assessed and presented clearly in a comprehensible manner according to the latest scientific standards.
The scientific findings of the molecular biologist, Dr. Claudia Friesen, from the Institute of Legal Medicine at the University of Ulm regarding the potential of methadone in tumor therapies look promising, but some questions remain unanswered. A major clinical study could answer these questions but would take years. An independent review of existing evidence, however, would provide a timely response of how credible the results are and whether doctors should prescribe off-label use of methadone to patients with no other hope. The cooperation with interested clinics, medical faculties, doctors and scientists is addressed by TAS e.V. and is expressly desired.
According to the collective opinion on "Tumor therapy with Methadone" from the Medical Faculty of the University of Ulm, the Ulm University Hospital and the Comprehensive Cancer Center Ulm from 23.08.2016, they strongly support conducting clinical trials to investigate the efficacy and tolerability of methadone therapy in patients with tumor diseases using established scientific standards. A prerequisite for this is that "solid preclinical data support a corresponding study."
To this end, TAS e.V. will contribute by analyzing all existing preclinical data and scientific findings on tumor therapy with methadone due to the controversial nature of the topic.
TAS e.V. operates on the basis of donations and depends on your support. TAS e.V. rejects any influence by drug manufacturers and companies in this sector as well as their employees, and economically dependent persons or companies as supporters.
Even if each person with cancer donated only one euro, it would suffice!